What is ipamorelin and how is it dosed?

Ipamorelin is a selective growth hormone releasing peptide (GHRP) that stimulates the pituitary gland to release growth hormone. It is dosed in micrograms per injection — typically 200–300 mcg per injection, administered 1–3 times daily. Common protocols inject once before sleep, or twice daily (morning and bedtime). Ipamorelin is frequently stacked with a GHRH peptide like CJC-1295 (no DAC) to maximize GH pulse amplitude.

How do I calculate ipamorelin syringe units from a mcg dose?

First, calculate your vial concentration: concentration (mcg/mL) = vial mg × 1,000 ÷ BAC water mL. Then: units to draw = (dose in mcg ÷ concentration) × 100 for a U-100 syringe. Example: 5 mg vial + 3 mL BAC water = 1,667 mcg/mL. A 300 mcg dose = 300 ÷ 1,667 × 100 = 18 units on U-100 (0.18 mL). At 2 mL BAC water (2,500 mcg/mL), 300 mcg = 12 units — workable but slightly less precise.

Why is ipamorelin usually stacked with CJC-1295?

Ipamorelin (a GHRP) triggers GH release, while CJC-1295 (no DAC) is a GHRH analog that amplifies the natural GH pulse. Used together, they work synergistically: the GHRH increases the number of somatotrophs responding to the pulse, and the GHRP triggers the release. The combined GH pulse is larger than either peptide alone. They are typically drawn into the same syringe and injected together.

How much BAC water should I add to an ipamorelin vial?

Because ipamorelin doses are small (200–300 mcg), a more dilute concentration improves measurement accuracy. A 5 mg vial with 3 mL BAC water gives 1,667 mcg/mL — a 300 mcg dose ≈ 18 units on U-100. Adding only 2 mL gives 2,500 mcg/mL where 300 mcg = 12 units, which is harder to measure exactly. If you are stacking with CJC-1295, both can be reconstituted separately and drawn into the same syringe.

When should I inject ipamorelin?

Ipamorelin is typically injected 30–60 minutes before sleep to coincide with the natural nocturnal GH pulse, which is the largest pulse of the day. Some protocols add a second injection in the morning on an empty stomach. Injecting with food or elevated blood sugar (particularly insulin) blunts the GH response, so most researchers fast for at least 2 hours before injecting. Injecting before bed on an empty stomach maximizes the pituitary response.

How should reconstituted ipamorelin be stored?

Reconstituted ipamorelin in BAC water should be refrigerated at 2–8°C and used within 28 days. Avoid freeze-thaw cycles. Lyophilized ipamorelin powder is stable for 1–2 years when stored frozen at −20°C. Always wipe the vial stopper with an alcohol swab before each draw and use a fresh needle per injection.

What are the benefits of ipamorelin?

Ipamorelin stimulates the pituitary to release growth hormone pulses, which raises IGF-1 levels over time. This leads to improved body composition (increased lean muscle mass, reduced fat), better sleep quality — particularly more restorative slow-wave sleep — faster recovery from exercise, and improved skin texture and thickness. Ipamorelin is considered the "cleanest" GHRP because, unlike GHRP-2 or hexarelin, it does not meaningfully raise cortisol, prolactin, or ACTH alongside GH, minimizing unwanted hormonal side effects.

What are the side effects of ipamorelin?

The most common side effects are water retention (from elevated GH/IGF-1), a transient GH "flush" (warmth, tingling, mild headache lasting 10–30 minutes post-injection), increased appetite, and mild fatigue. Injection site reactions are possible but typically minor. Rare reports include transient hypoglycemia shortly after injection. Long-term high-dose use may lead to receptor desensitization, reducing effectiveness — cycling protocols (e.g., 3 months on, 1 month off) are common to mitigate this.

Ipamorelin Dosage Calculator

Calculates syringe units and injection volume for ipamorelin doses in mcg from vial size and BAC water volume.

How Ipamorelin Dosage Calculation Works

This ipamorelin dosage calculator converts your dose in mcg to U-100 or U-40 syringe units based on your vial size and BAC water volume. Ipamorelin is dosed in micrograms — typically 200–300 mcg per injection — and choosing the right BAC water volume is important for drawing an accurate, readable unit count.

Concentration (mcg/mL) = Vial size (mg) × 1,000 ÷ BAC water added (mL)
Units to draw = (Target dose in mcg ÷ Concentration) × 100 for U-100 syringe

Example: 5 mg vial + 5 mL BAC water = 1,000 mcg/mL. A 300 mcg dose = 300 ÷ 1,000 × 100 = 30 units on U-100 (0.30 mL). Enter your values above and the calculator handles the math instantly.

Ipamorelin Dose Reference — U-100 Syringe Units

Common ipamorelin doses and their syringe unit equivalents at two BAC water volumes:

200 mcg at 1,667 mcg/mL (5 mg + 3 mL): ≈ 12 units on U-100 — 0.12 mL
300 mcg at 1,667 mcg/mL: ≈ 18 units on U-100 — 0.18 mL
200 mcg at 2,500 mcg/mL (5 mg + 2 mL): 8 units on U-100 — 0.08 mL (harder to measure accurately)
300 mcg at 2,500 mcg/mL: 12 units on U-100 — 0.12 mL

The 3 mL BAC water default keeps draws in the 12–18 unit range — a reasonable balance between precision and volume. Use the peptide reconstitution calculator to model your specific vial size and BAC water volume.

AdvertisementResponsive Ad

Stacking Ipamorelin with CJC-1295

Ipamorelin (GHRP) and CJC-1295 no-DAC (GHRH) are the most commonly stacked GH peptides. They work via complementary mechanisms: the GHRH analog amplifies the number of pituitary cells ready to release GH, while ipamorelin triggers the actual release. Together, they produce a GH pulse significantly larger than either peptide alone.

A typical stack uses 200–300 mcg of each, drawn into the same insulin syringe and injected together. Reconstitute each peptide separately, then draw the ipamorelin dose first, followed by the CJC-1295 dose into the same syringe. See the CJC-1295 dosage calculator for CJC-1295-specific unit math.

Injection Timing for Maximum GH Response

Ipamorelin is most effective injected on a fasted stomach — elevated insulin levels from a recent meal significantly blunt the GH pulse. Common timing strategies:

Bedtime only (1x/day): Inject 30–60 minutes before sleep on an empty stomach. This amplifies the natural nocturnal GH pulse, the largest of the day.
Morning + Bedtime (2x/day): Add a morning injection after an overnight fast. Doubles total daily exposure.
Three times daily (3x/day): Morning, afternoon, and bedtime injections. Used in some higher-intensity protocols; requires fasting before each injection.

Ipamorelin vs. Other GH Peptides

Ipamorelin is valued for its selectivity — unlike GHRP-2 or hexarelin, it does not significantly raise cortisol or prolactin alongside GH. Sermorelin and tesamorelin are GHRH analogs (not GHRPs), which means they work by a different mechanism and are best used as ipamorelin stack partners rather than alternatives. For GHRH-only protocols, see the sermorelin dosage calculator and tesamorelin dosage calculator.

AdvertisementResponsive Ad

Ipamorelin Benefits and Research

Ipamorelin's defining feature among GH-releasing peptides is its selectivity. Most GHRPs (such as GHRP-2 and hexarelin) stimulate GH release but also significantly raise cortisol, prolactin, and ACTH — hormones whose elevation can blunt the benefits of increased GH. Ipamorelin achieves meaningful GH stimulation with minimal impact on these other hormones, making it the preferred GHRP for ongoing protocols where cortisol elevation would be counterproductive.

The mechanism works through ghrelin receptors (GHS-R1a) on pituitary somatotrophs. When activated by ipamorelin, these receptors trigger GH release in pulses that elevate circulating IGF-1 over time. Research in animal models demonstrated that ipamorelin stimulated GH release at roughly 10–15× the amplitude of baseline pulses without the cortisol spike seen with other GHRPs. This elevated IGF-1 drives the benefits users seek: improved body composition, enhanced recovery, and better sleep architecture.

GH pulse amplitude: 10–15× baseline in animal studies with minimal cortisol co-stimulation
Body composition: increased lean muscle mass and reduced fat mass from sustained IGF-1 elevation
Sleep quality: deeper slow-wave sleep reported by users, consistent with known GH/IGF-1 sleep effects
Recovery: improved tissue repair and reduced muscle soreness reported in user communities
Skin and hair: secondary effects of IGF-1 elevation; commonly reported after 8–12 weeks of use

Ipamorelin Side Effects and Safety

Ipamorelin's side effect profile is considered mild relative to other GHRPs, primarily because it does not significantly elevate cortisol or prolactin. The most common effects are related to the GH response itself rather than off-target receptor activity.

GH flush — warmth, tingling, or mild headache lasting 10–30 minutes after injection; transient and typically diminishes after the first few weeks
Water retention — mild edema from elevated GH/IGF-1; usually resolves with dose adjustment
Increased appetite — expected from GH/ghrelin receptor activity; monitor caloric intake
Fatigue — mild, particularly after the first injection; typically resolves within the first week
Injection site reactions — minor pain or erythema; rotate injection sites to minimize
Receptor desensitization — with prolonged high-frequency dosing; cycling protocols (3 months on, 1 month off) are standard practice
Transient hypoglycemia — rare; most likely when injecting on a very empty stomach with no meal within 4–6 hours

Ipamorelin is not FDA-approved for human use. It is available as a research peptide. Use only under the guidance of a licensed healthcare provider, particularly if you have a history of pituitary disorders, cancer, or diabetes, as GH elevation can affect glucose metabolism and IGF-1 levels.

Storage and Safe Handling

Refrigerate reconstituted ipamorelin at 2–8°C and use within 28 days. Never freeze reconstituted peptide. Lyophilized powder should be stored frozen at −20°C for long-term storage. Wipe the vial stopper with an alcohol swab before each draw, and use a fresh needle for every injection. Dispose of sharps in a puncture-resistant container.

Sources & References

Bacteriostatic Water for Injection — FDA Information — U.S. Food and Drug Administration
Insulin Syringe and Injection Guidance — American Diabetes Association
Safe Injection Practices and Reconstitution Guidance — Centers for Disease Control and Prevention